Ketamine for acute ischemic stroke
Part of Brain & nervous system, Heart & circulation clinical trials.
This trial tests whether a single dose of ketamine, given within 24 hours of a stroke, can reduce brain damage and improve recovery. It is designed for people who had a recent ischemic stroke and who are not eligible for standard clot-busting or clot-removal treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have had an ischemic stroke (a blockage in a blood vessel in the brain) within the last 24 hours.
- You must have had a stroke confirmed by an MRI scan.
- Before the stroke, you must have been able to take care of yourself (modified Rankin score 0–2).
- You must not be eligible for standard treatments like IV Alteplase (a clot-busting drug) or mechanical thrombectomy (clot removal).
- You must be willing to provide written consent (or have a family member/caregiver do so).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a clot-busting drug for people who had a stroke more than 4.5 hours ago. It uses a special CT scan to see if the treatment can still help them.
This trial tests whether a drug called urinary kallidinogenase can help people who have had a stroke caused by a blocked artery in the brain. The drug is given within 48 hours of the stroke, and the study hopes to see if it improves recovery and reduces disability.
This Phase 4 study tests whether using a specific calming medicine (dexmedetomidine) for a longer period after a successful clot-removal procedure helps people do better in the long term. It may help improve outcomes after ischemic stroke where the clot is successfully treated.
This trial tests a clot-busting drug for people who had a stroke but don't know when it started, like waking up with symptoms. It may help reduce disability if given soon after noticing symptoms.
This trial tests whether a single dose of ketamine can quickly improve depression by studying brain chemical changes using MRI. It's for people with treatment-resistant depression who haven't used ketamine before.
This study tests whether ketamine can help stop seizures that haven't responded to standard treatments. It's for people with a serious condition called status epilepticus, where seizures don't stop on their own.
Hear when a new Acute Ischemic Stroke trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.